Visiongain has published a new report on Transdermal Drug Delivery Market Report 2021-2031: Forecasts by Type (Patches and Semisolid formulations), Applications (Pain Management, Central Nervous System Disorders, Hormonal Applications, Cardiovascular Diseases), End-User (Homecare settings, Hospitals, and clinics. PLUS, Profiles of Leading Pharma Contract Manufacturing Companies and Regional and Leading National Market Analysis. PLUS, COVID-19 Recovery Scenarios.
The market is majorly driven by the increasing prevalence of chronic diseases, where conventional drug delivery systems, such as oral drugs have lower potency due to the hepatic first-pass metabolism.
Download Exclusive Sample of Report @ https://www.visiongain.com/report/transdermal-drug-delivery-market-2021/#download_sampe_div
Transdermal drug delivery systems are an alternative to oral intravascular, subcutaneous and intra-mucosal routes, wherein the drugs are delivered through the skin for therapeutic use.
COVID-19 Impact on Transdermal Drug Delivery Market
Transdermal Drug Delivery Market is growing well in the period of this pandemic Covid 19, because the patients who is having chronic diseases which is mentioned above need treatment at their home itself because the threat of this pandemic restricts the patient to visit frequently to hospitals.
Market Drivers
Rise in increase of chronic disorders and geriatric population -
- The rise in geriatric population poses risk for increase in incidence of diabetes. So aged people are more susceptible to type 2 diabetes, which are in the need of these medicines for their treatment, this in-turn will boost the growth of Transdermal Drug Delivery market.
Market Opportunities
- High occurrence of cardiovascular disorders such as hypertension makes it an attractive market for transdermal drug delivery systems.
- The market has witnessed development of new adhesive, molecular absorption enhancers, and penetration enhancers that are expected to enhance skin permeability, resulting expansion the range of drugs that are expected to be delivered through transdermal route. This enables the growth of the market.
Get Detailed TOC @ https://www.visiongain.com/report/transdermal-drug-delivery-market-2021/#download_sampe_div
Competitive Landscape
Global Transdermal drug delivery market is highly fragmented and the major players have implemented various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions and others to increase their footprints in this market. Hisamitsu Pharmaceutical (Japan), Mylan (US), UCB (Belgium), Novartis (Switzerland), GlaxoSmithKline (UK), Boehringer Ingelheim (Germany), Johnson & Johnson (US), Endo International (Ireland), and Purdue Pharma (US).
Recent Developments
- Hisamitsu is a leading company in the field of medicines for external use. The company is an investor in the field of transdermal patches. For instance, in 2017, the firm spent over USD 14.0 million compared to USD 12.8 million in 2016 on R&D activities.
- Mylan is among the leading players in the transdermal drug delivery systems market. The company endeavors to design, develop, and manufacture high-quality, innovative transdermal drug delivery systems, such as adhesive patches. These medicines treat a variety of conditions across several therapeutic categories. In order to strengthen its position in the market, the company significantly invests in R&D activities. In 2017, the company invested USD 783.3 million in R&D accomplishments to invent and introduce new products in the market as compared to USD 826.8 million in 2016.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with this invaluable business intelligence.
To access the data contained in this document please email contactus@visiongain.com
Information found nowhere else
With our newly report title, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Transdermal drug delivery market and leading companies. You will find data, trends and predictions.
Find more Visiongain research reports on Therapeutic Drugs Sector click on the following links:
- Animal Vaccine Market
- Anticoagulants Market
- Antidiarrheal Drug Market
- Anti-acne Cosmetic Market
- Anti-neoplastic Agents Market
- Anti-snoring Treatment Market
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: catherine.walker@visiongain.com
About Visiongain
Visiongain is one of the fastest growing and most innovative, independent, market intelligence around, the company publishes hundreds of market research reports which it adds to its extensive portfolio each year. These reports offer in-depth analysis across 18 industries worldwide. The reports cover a 10-year forecast, are hundreds of pages long, with in depth market analysis and valuable competitive intelligence data. Visiongain works across a range of vertical markets, which currently can influence one another, these markets include automotive, aviation, chemicals, cyber, defense, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors. Our customized and syndicated market research reports mean that you can have a bespoke piece of market intelligence customized to your very own business needs.
Contact:
Catherine Walker
PR at Visiongain Inc.
Tel: + 44 0207 336 6100
USA Tel: + 1 718 682 4567
EU Tel: + 353 1 695 0006
Toll Free: 00-1-646-396-5129
Email: catherine.walker@visiongain.com
Web: https://www.visiongain.com
Follow Us: LinkedIn | Twitter
-
SOURCE Visiongain Limited.
